Effect of rimonabant on weight and cardiometabolic risk factors.
Gadde
Kishore M
KM
D019440:Anti-Obesity Agents / Q000009:adverse effects*; D001007:Anxiety / Q000209:etiology; D003863:Depression / Q000209:etiology; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000523:psychology*; D010880:Piperidines / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors*; D000077285:Rimonabant; D012307:Risk Factors
D019440:Anti-Obesity Agents; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D000077285:Rimonabant